straits-research-logo (1).png
Global Acne Treatment Market Revenue is Estimated to Reach USD 9,138.04 million by 2031, Growing at a CAGR of 5.13%: Straits Research
February 08, 2024 10:10 ET | Reed Intelligence
New York, United States, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Acne is a skin condition that results from clogged skin openings and pores, including hair follicles. Most people who tend to follow this...
22157.jpg
Global Crow's Feet Market Analysis Uncovers Growth Trends and Predictions Through 2031
January 31, 2024 10:47 ET | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Crows Feet Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user,...
Global Scleroderma Market
Global Scleroderma Market Forecasts Promising Growth with Latest Industry Trends by 2027
January 30, 2024 20:25 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Scleroderma Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global scleroderma market is poised for...
22157.jpg
Dermatitis Global Market Report 2024: Analysis Reveals Key Trends in Biologics and Personalized Medicine Approaches - Long-term Forecasts to 2028 and 2033
January 26, 2024 03:32 ET | Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Dermatitis Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. There is significant growth underway in the global...
Global Hyaluronic Acid-based Dermal Fillers Market
Global Hyaluronic Acid-based Dermal Fillers Market 2024-2034: Single-Phase Products Have Emerged as a Dominant Segment; Wrinkle Correction Applications Leads in Revenue Generation
January 24, 2024 14:27 ET | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Hyaluronic Acid-based Dermal Fillers Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. ...
logo.jpg
Fighting leprosy with artificial intelligence: DAHW and Belle.ai join forces with Senegal’s Ministry of Health and Social Action to detect and combat neglected diseases
January 24, 2024 05:05 ET | Belle.ai
DAHW, Belle.ai and Senegal's Ministry of Health will deploy Belle.ai’s smartphone-based skin AI software to help Senegal eliminate leprosy by 2030.
Waldorf Logo.jpg
The Waldorf Center for Plastic Surgery Announces a New Partnership
January 22, 2024 15:32 ET | The Waldorf Center for Plastic Surgery
PORTLAND, Ore., Jan. 22, 2024 (GLOBE NEWSWIRE) -- The Waldorf Center for Plastic Surgery in Portland is excited to announce a new partnership with Forefront Dermatology Group—a medical team that...
Regeneron Logo.jpg
Dupixent® (dupilumab) U.S. Label Updated with Data Further Supporting Use in Atopic Dermatitis with Moderate-to-Severe Hand and Foot Involvement
January 16, 2024 07:00 ET | Regeneron Pharmaceuticals, Inc.
Data included from first and only Phase 3 trial specifically evaluating a biologic in this difficult-to-treat population Phase 3 trial showed more than twice as many patients treated with Dupixent...
Stretch Marks Treatment Market to Witness Exponential Growth, Projected to Reach US$ 4.6 Billion by 2033: According to Persistence Market Research, Inc
January 12, 2024 03:34 ET | Persistence Market Research
New York, Jan. 12, 2024 (GLOBE NEWSWIRE) -- Market Size & Overview:  The Global Stretch Marks Treatment Market experienced a Compound Annual Growth Rate (CAGR) of 4.8% from 2012 to 2022,...
Novartis' Cosentyx S
Novartis' Cosentyx Shows Promising Early Progress in Treating Hidradenitis Suppurativa, Poised for Significant Future Adoption at the Expense of AbbVie's Humira
January 10, 2024 15:58 ET | Spherix Global Insights
Exton, Pennsylvania, Jan. 10, 2024 (GLOBE NEWSWIRE) -- In late October 2023, the FDA granted approval to Novartis' Cosentyx (secukinumab) for treating hidradenitis suppurativa (HS), marking it as...